CSIMarket
 
Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 
 

Aclaris Therapeutics Inc Income Statement Annual

ACRS


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Annual GAAP In millions $)

(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Revenue From Contract With Customer Excluding Assessed Tax 31.25 29.75 6.76 6.48 4.23
Revenue From Contract With Customer Excluding Assessed Tax - - - - -
Total Revenue 31.25 29.75 6.76 6.48 4.23
Cost of Revenue 3.42 4.02 4.71 5.13 4.06
Gross Profit 27.83 25.73 2.05 1.35 0.17
Selling, Administration, Marketing 32.41 25.13 23.62 20.53 27.83
Depriciation & Amortization - - - - -
Research and Development Expense 98.38 77.81 43.81 31.73 64.90
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6.63 - - - 18.50
Other operatinig exp. /-income -12.24 12.64 - 0.00 0.00
Unusual Expense /-Income - - - - -
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability - - 24.34 - -
Total operating costs including COS 128.61 119.61 96.48 57.39 115.29
Operating income/-loss -97.36 -89.85 -89.72 -50.91 -111.06
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Loss/ -Gain on Investment - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -8.51 -2.95 1.14 0.42 50.30
Total costs & expenses 120.10 116.66 97.63 57.82 165.58
Income /-loss before income taxes -88.85 -86.91 -90.87 -51.34 -161.35
Income taxes expenses/-benefit -0.37 - - -0.18 -
Income after income taxes -88.48 -86.91 -90.87 -51.15 -113.54
Net income/-loss of other equity - - - 0.00 47.81
Income/-loss from cont. Ops. -88.48 -86.91 -90.87 -51.15 -113.54
Accounting change - - - - -
Discontinued operations - - - 0.14 -47.81
Extraordinary items - - - - -
Net Income/-loss -88.48 -86.91 -90.87 -51.02 -161.35
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -88.48 -86.91 -90.87 -51.02 -161.35
EBIT -88.85 -86.91 -90.87 -51.34 -161.35
EBITD -87.99 -86.11 -89.94 -50.01 -154.95
EBITDA -87.99 -86.11 -89.94 -50.01 -154.95


Per Share (GAAP Annual, in $) (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Basic EPS (excl. extra items) -1.27 -1.33 -1.60 -1.20 -3.90
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -1.27 -1.33 -1.60 -1.20 -3.90
Basic shares outstanding (Mill. of Units) 69.81 65.21 56.73 42.54 41.32
   EPS other shares - - - - -
Diluted Net EPS -1.27 -1.33 -1.60 -1.20 -3.90
Diluted average shares (Mill. of Units) 69.81 65.21 56.73 42.54 41.32
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com